Kexing Biopharm’s overseas commercial product——Paclitaxel for Injection (Albumin-Bound)
Recently, albumin-bound paclitaxel for injection, an oncology product introduced by Kexing Biopharm in collaboration with Haichang Biotech, has received marketing authorization from Argentina’s National Administration of Drugs, Foods and Medical Devices…
